Tubing and Extrusion Supplier Qualification for Medical Devices: From Audit to Validation

How to qualify a medical tubing and extrusion supplier — covering supplier selection criteria, quality system audit, IQ/OQ/PQ process validation, dimensional specification control, material traceability, cleanroom requirements, quality agreement structure, and ongoing monitoring for catheter, IV set, and fluid delivery tubing under FDA QMSR, ISO 13485, and EU MDR.

Why Tubing and Extrusion Supplier Qualification Is Different from Other Component Sourcing

Extruded medical tubing is not a purchased part that arrives finished and ready for assembly. It is a process output — the result of a tightly controlled thermal and mechanical transformation where raw polymer pellets are melted, forced through a precision die, cooled under controlled conditions, and cut or wound to length. The tubing's dimensions, mechanical properties, surface finish, and biocompatibility are all determined by the interaction of the resin, the extrusion parameters, the tooling, and the downstream equipment.

This means that qualifying an extrusion supplier is fundamentally different from qualifying a supplier of molded parts, machined components, or electronic assemblies. You are not just evaluating whether the supplier can produce parts that meet your print. You are evaluating whether the supplier can control a continuous process well enough that every meter of tubing, across every production run, meets your specifications — and whether they can reproduce those results consistently over the life of your device.

The FDA's process validation guidance, ISO 13485:2016, and the GHTF Process Validation Guidance (GHTF/SG3/N99-10:2004 Edition 2) all converge on the same principle: when a process output cannot be fully verified by subsequent inspection and testing, the process itself must be validated. Extrusion of medical tubing is a textbook example. You cannot inspect every millimeter of a 100-meter tube run. You must validate that the process produces conforming product.

This article provides a comprehensive framework for qualifying a tubing and extrusion supplier, from initial capability assessment through audit, process validation, ongoing monitoring, and lifecycle management.

Understanding the Extrusion Process for Medical Tubing

Single-Lumen Extrusion

Single-lumen tubing — one continuous channel through the center — is the most basic extrusion format. It is used for IV sets, catheter shafts, respiratory circuits, feeding tubes, and drainage tubing. The process involves feeding polymer resin into an extruder, melting it at a controlled temperature profile, forcing the melt through a circular die, and cooling the extrudate in a water bath or with air cooling while maintaining dimensional control through vacuum sizing or internal pressure.

Critical process parameters for single-lumen extrusion include:

Extruder temperature profile: Multiple heating zones along the barrel must be controlled to achieve consistent melt quality without degrading the polymer. Different resins require different temperature profiles — PVC processes at 160-190°C, while PEEK requires 370-400°C.
Screw speed and feed rate: These determine the output rate and affect the melt's residence time, shear history, and homogeneity.
Puller speed: The haul-off speed determines the tubing's wall thickness and outer diameter. Faster puller speeds produce thinner walls; slower speeds produce thicker walls.
Vacuum sizing pressure: For tubing that requires tight OD control, vacuum sizing tanks apply external pressure to the molten tube as it cools, holding it against a sizing plate to maintain the target OD.
Cooling water temperature and flow: These affect crystallinity, dimensional stability, and surface finish.

Multi-Lumen Extrusion

Multi-lumen tubing contains two or more channels within a single tube structure. It is used in cardiovascular catheters (separate channels for guidewire, inflation, and aspiration), endoscopes (channels for instruments, air/water, and suction), and drug delivery devices (simultaneous delivery of multiple fluids).

Multi-lumen extrusion requires precision-engineered tooling — the die tip and pin assembly that forms the internal lumens — and tighter control over process parameters because any variation affects the geometry of all lumens simultaneously. Duke Extrusion manufactures custom multi-lumen tubing in configurations up to 24 lumens, with eccentric-shaped lumens (crescent, oblong, square) and unique profile outer diameters. DuPont's Spectrum Plastics Group produces thin-wall tubing with walls as thin as 0.0005 inches (0.0127 mm) through their Apollo free-extrusion process.

Multi-lumen qualification is more demanding because:

Each lumen must meet its own dimensional specification (ID, cross-sectional area, concentricity)
The relationship between lumens (spacing, orientation, wall thickness between lumens) must be controlled
Functional performance (flow rate through each lumen, burst pressure, kink resistance) depends on the combined geometry

Co-Extrusion and Multi-Layer Tubing

Co-extrusion combines two or more materials in a single tube cross-section. A typical application is a catheter shaft with a lubricious inner layer (PTFE or similar) for reduced friction, a structural middle layer (Nylon or Pebax) for pushability, and a soft outer layer (TPU) for patient comfort.

Co-extrusion requires multiple extruders feeding a common die, with precise control over the relative flow rates, temperatures, and adhesion between layers. Qualifying a co-extrusion supplier involves validating each material stream and their interaction at the die.

Bump and Tapered Extrusion

Bump extrusion produces tubing with varying outer diameter along its length — a larger-diameter proximal section that transitions to a smaller-diameter distal section. This is used for catheter shafts that need a stiff proximal end for pushability and a flexible distal end for navigation.

Tapered extrusion is a related process where the tubing's diameter changes continuously along its length. Both processes require synchronized control of puller speed and/or extruder output to produce the diameter transition at the correct location and with the correct profile.

Profile Extrusion

Profile extrusion produces non-circular cross-sections — flat strips, C-channels, D-profiles, and complex custom shapes used in surgical instruments, guide catheters, and fluidic devices. Profile tooling is more complex than circular die tooling, and dimensional control is more challenging because the extrudate's shape changes as it cools and the polymer relaxes.

Supplier Selection Criteria

Technical Capability Assessment

Before investing in a formal audit, evaluate the supplier's technical capabilities against your requirements:

Materials expertise: What polymers does the supplier routinely process? Do they have experience with the specific resin you need? A supplier who specializes in PVC medical tubing may not have the tooling or process expertise to produce PEEK or PTFE tubing. Proterial Cable America's High Performance Medical Solutions division lists extensive experience with thermoplastics and workhorse materials including PP, PE, PVC, TPU, Nylon, and Pebax, plus high-temperature resins like PEEK and PSU.

Dimensional capability: What tolerances can the supplier consistently hold? For medical tubing, OD tolerances of ±0.01 mm to ±0.03 mm are achievable with modern extrusion lines using closed-loop laser diameter measurement and PLC control. If your application requires tighter tolerances, verify that the supplier has the metrology and process control equipment to achieve them.

Tube complexity: Can the supplier produce the tube configuration you need — single-lumen, multi-lumen, co-extruded, bump, profile? Multi-lumen tubing with complex lumen geometries requires specialized tooling design capabilities. Zeus Industrial Products manufactures multi-lumen extrusions in PTFE, ePTFE, FEP, PFA, PEEK, TPU, and other resins with customizable lumen configurations.

Tooling capability: Does the supplier design and build their own tooling, or do they rely on external tooling shops? In-house tooling capability provides faster iteration during development and better control over tooling maintenance during production. Proterial PCA-HPMS designs and manufactures all tooling in-house, reducing costs and eliminating dependence on outside suppliers.

Secondary operations: Does the supplier offer value-added services such as tipping, flaring, hole punching, marker band placement, bonding, and assembly? If your device requires these operations, sourcing them from the same supplier reduces complexity, lead time, and quality risk.

Quality System Assessment

ISO 13485 certification: This is the baseline requirement for a medical tubing supplier. ISO 13485 certification demonstrates that the supplier has a quality management system designed for medical device manufacturing, including risk management, design controls (if applicable), process validation, and traceability. Systematic Extrusion emphasizes that ISO 13485 ensures process validation, material traceability, risk management, and cleanroom standards are systematically embedded in every stage of medical tubing production.

FDA registration: If the supplier's tubing is considered a medical device component or if the supplier performs operations that fall under device manufacturing, FDA registration (establishment registration and device listing) may be appropriate.

Cleanroom capability: What cleanroom classification does the supplier maintain for extrusion and secondary operations? ISO Class 7 or Class 8 cleanrooms are typical for medical tubing production. Verify that the cleanroom is qualified with environmental monitoring data and that gowning and access controls are in place.

Traceability system: How does the supplier track material from incoming resin lot through extrusion to finished tubing lot? Can they demonstrate end-to-end traceability in their records? ISO 13485 requires that every batch of polymer used in tubing must be traceable from supplier to final product.

Change control procedures: How does the supplier manage changes to their processes, materials, tooling, and equipment? Do they notify customers of changes? What is their change control procedure, and how does it align with your own change control expectations?

Capacity and Business Assessment

Production capacity: Does the supplier have sufficient extrusion line capacity to meet your current and projected volumes? If your device grows from 10,000 units per year to 100,000 units per year, can the supplier scale?

Lead times: What are typical lead times for development builds, first articles, and production orders? Duke Extrusion offers the shortest lead times in the industry for custom medical tubing, which matters when development timelines are compressed.

Financial stability: Is the supplier financially stable enough to support your product through its lifecycle? The medical tubing extrusion market has seen consolidation (DuPont's acquisition of Spectrum Plastics Group and Donatelle Plastics, for example), and a supplier acquisition can disrupt supply.

Geographic location: Where are the supplier's manufacturing facilities? Proximity matters for development iterations, audit access, and shipping logistics. Optinova, founded in 1971, operates four extrusion plants in Finland, Thailand, and the US to serve partners from 50+ countries.

The Supplier Audit

Audit Scope

A tubing and extrusion supplier audit should cover:

Quality management system: Review the supplier's QMS documentation, including quality manual, procedures, and records. Verify ISO 13485 certification scope and recertification schedule.

Facility and equipment: Walk the production floor. Observe the extrusion lines in operation. Verify equipment condition, maintenance records, calibration status, and environmental controls. Medical Extrusion Technologies (MET) has over 35 years of experience in custom tubing extrusions, operating from facilities in California, Texas, and Minnesota.

Material control: Review incoming material inspection procedures. Verify that resin lots are quarantined until released, that CoA review is documented, and that storage conditions (temperature, humidity for hygroscopic materials) are controlled.

Process control: Review extrusion process monitoring records. Are critical process parameters (temperatures, speeds, pressures) recorded in real time? Is there a statistical process control (SPC) system in place? How are out-of-specification conditions detected and corrected?

Metrology: Review the supplier's measurement capabilities. For medical tubing, critical dimensions include OD, ID, wall thickness, concentricity, and length. Verify that measurement equipment is calibrated and that measurement system analysis (MSA) has been performed.

Traceability: Trace a finished tubing lot backward through the supplier's records to the incoming resin lot, the production date, the extrusion line, the operator, and the process parameters. This exercise reveals the practical effectiveness of the supplier's traceability system.

Nonconformance management: Review recent nonconformance records and CAPA reports. How does the supplier identify, contain, investigate, and correct quality problems?

Cleanroom qualification: If production occurs in a cleanroom, review the cleanroom qualification report, environmental monitoring data, and gowning/access procedures.

Key Audit Questions

What is your procedure for validating a new extrusion process? Can you share a sample IQ/OQ/PQ protocol?
How do you handle a change to the resin grade or supplier? What is the notification process for your customers?
What is your approach to tooling maintenance? How often are dies and pins inspected and replaced?
How do you manage the transition between production runs of different tubing configurations on the same line? What cleaning and changeover procedures are in place?
What is your incoming material acceptance process for resin? Do you perform any incoming testing beyond CoA review?
How do you control and monitor the extrusion process in real time? What parameters are continuously recorded?
What is your capacity utilization rate, and how would you accommodate a significant increase in our order volume?

Process Validation: IQ, OQ, and PQ for Extrusion

Validation Ownership

A critical question for every medical device OEM: who is responsible for process validation — the OEM or the extrusion supplier?

The regulatory expectation is clear. Under FDA 21 CFR Part 820 (now QMSR, effective February 2, 2026) and ISO 13485, the legal manufacturer is responsible for ensuring that all processes used to manufacture their device are validated. This responsibility cannot be delegated to the supplier through a quality agreement. The OEM must either perform the validation themselves or directly oversee the supplier's execution of the validation.

In practice, this means:

The OEM develops or approves the validation protocol (IQ/OQ/PQ).
The OEM approves the validation report.
The OEM's quality unit signs off on the completed validation before production tubing is released for device assembly.

The supplier provides the execution capability, the equipment, and the process expertise. Medical Design Briefs notes that most OEMs simply don't have a validation plan for a contract manufacturer to follow — and that this gap creates risk for both parties.

Installation Qualification (IQ)

IQ verifies that the extrusion equipment is installed correctly and that all utilities, safety systems, and measurement instruments are functional:

Verify extruder model, screw design, and barrel specifications against the equipment documentation.
Confirm electrical supply, compressed air, and cooling water connections.
Verify calibration of temperature controllers, pressure transducers, laser micrometers, and puller speed controllers.
Document the tooling (die and pin) identification, dimensions, and condition.
Verify that the cleanroom or production environment meets the specified classification.

Operational Qualification (OQ)

OQ establishes the process window — the range of process parameter settings that produce conforming tubing. This is done by systematically challenging the process at the upper and lower limits of each critical parameter:

Temperature challenge: Run the extruder at the minimum and maximum barrel temperature settings while monitoring tubing dimensions and visual quality.
Speed challenge: Vary screw speed and puller speed across their specified ranges to determine the boundary where dimensional specifications begin to fail.
Vacuum sizing challenge: Adjust vacuum pressure across its range to determine the minimum and maximum vacuum levels that produce acceptable OD control.
Cooling challenge: Vary water bath temperature and flow rate to assess their impact on dimensional stability and surface finish.

For each challenge run, measure the tubing's critical dimensions (OD, ID, wall thickness, concentricity) and compare against specifications. The OQ report defines the proven acceptable ranges for each process parameter.

Medical Extrusion Technologies explains that OQ verifies that equipment operates as intended by testing each component to confirm operation at pre-set thresholds, using worst-case conditions to determine the process window.

Performance Qualification (PQ)

PQ demonstrates that the process consistently produces conforming product under normal operating conditions:

Run a minimum of three consecutive production lots at the nominal process settings established during OQ.
Use at least two different lots of raw material to demonstrate that the process is robust against incoming material variability. Medical Design Briefs recommends performing a minimum of three different setups with two distinct lots of raw material, showing repeatability of the process setup while also accounting for lot-to-lot variability.
Measure critical dimensions on samples taken at defined intervals throughout each lot (beginning, middle, end).
Perform functional testing as applicable (burst pressure, flow rate, kink resistance).
Document all results in the PQ report. If all lots meet specifications, the process is considered validated.

Validation Documentation Package

The complete validation package should include:

Validation master plan (scope, approach, acceptance criteria)
IQ protocol and report
OQ protocol and report (including process parameter ranges)
PQ protocol and report (including lot results and statistical analysis)
Material specifications and lot traceability for all resin used in validation runs
Measurement system analysis for all critical measurements
Summary report with conclusion and approval signatures

Dimensional Specification and Tolerance

Defining What Matters

Not every dimension on a tubing drawing is equally critical. A rigorous specification distinguishes between:

Critical dimensions: Those that directly affect device function, patient safety, or assembly fit. For a catheter shaft, this might include the maximum OD (must pass through a guide catheter), the minimum ID (must accept a guidewire), and the minimum wall thickness (must withstand rated burst pressure).
Significant dimensions: Those that affect device performance but not safety. This might include concentricity (affects flow rate consistency) or surface finish (affects friction).
Reference dimensions: Those that are reported for information but do not have acceptance criteria. These might include cross-sectional area or lumen volume.

Tolerance Stack-Up Analysis

When tubing is assembled into a device with mating components, the tolerances of all interfacing parts must be analyzed together. A tolerance stack-up analysis determines whether the worst-case combination of tubing and mating part dimensions will still assemble and function correctly.

For example, if a catheter shaft's maximum OD is 1.35 mm ±0.03 mm, and the mating hub's minimum ID is 1.38 mm ±0.03 mm, the worst-case interference occurs when the shaft OD is 1.38 mm and the hub ID is 1.35 mm — a 0.03 mm interference that prevents assembly. The tolerance stack-up must demonstrate adequate clearance under all tolerance conditions.

Measurement Method Standardization

Discrepancies between the supplier's measurements and the OEM's measurements are a common source of quality disputes. To prevent this:

Define the measurement method for each critical dimension in the specification (e.g., "OD measured by laser micrometer at 500 mm intervals, per ASTM D3595").
Exchange golden samples — reference pieces of tubing that both parties measure and agree on the values — to align measurement systems.
Perform periodic measurement correlation studies where both parties measure the same lot and compare results.

Material Traceability and Lot Control

End-to-End Traceability Requirements

ISO 13485 requires that organizations maintain traceability records for product realization. For medical tubing, this means:

Incoming resin: Each lot of resin received by the supplier is identified by supplier lot number, material grade, quantity received, date received, and incoming inspection results.
Production records: Each production run of tubing is linked to the specific resin lot(s) used, the extrusion line and tooling employed, the process parameters recorded during the run, and the operator(s) who executed the run.
Finished tubing: Each finished tubing lot is assigned a unique lot number that links backward to the resin lots and production records and forward to the customer's purchase order and device assembly records.

Seaway Plastics emphasizes that complete material traceability from raw resin lot numbers through finished components is required to support potential recalls. This traceability must be verified during the supplier audit, not just documented in the quality manual.

Resin Lot Control at the Supplier

The supplier's resin handling practices directly affect lot-to-lot consistency:

Dedicated storage: Medical-grade resin should be stored separately from industrial-grade materials, in a controlled environment that prevents contamination and degradation.
Moisture control: Hygroscopic resins (Nylon, PETG, TPU, PEEK) must be dried before processing. The supplier's drying procedures, equipment, and monitoring should be reviewed during the audit.
First-in, first-out (FIFO): Resin should be consumed in the order it was received to prevent aging and expiration.
Segregation: Partial lots of resin should be clearly identified and stored to prevent commingling with other lots or grades.

Quality Agreement Structure

The quality agreement between the medical device OEM and the extrusion supplier must address provisions specific to tubing manufacturing:

Process Validation Ownership

Clearly state that the OEM owns the validation and that the supplier executes validation activities under OEM-approved protocols. Define who writes, reviews, and approves each validation document.

Change Notification

Specify the types of changes that require OEM notification and approval:

Changes to the resin grade, supplier, or formulation
Changes to the extrusion process parameters outside the validated range
Changes to the tooling (die, pin, or sizing equipment)
Changes to the manufacturing site, equipment, or cleanroom
Changes to the supplier's quality system (e.g., ISO 13485 certification scope changes)

Define the notification timeline (typically 60-90 days for planned changes, immediate for unplanned changes) and the approval process.

First Article and Lot Release

Define the first article inspection requirements for new tooling, new configurations, or after a process change. Specify the lot release process, including whether the supplier ships on their own release or holds lots pending OEM review and approval.

Nonconformance Notification

Require the supplier to notify the OEM of any nonconforming product within a defined timeline (typically 24-48 hours of discovery). Define the containment, investigation, and corrective action expectations.

Right to Audit

Reserve the right to audit the supplier's facility and records, either directly or through a designated third party, with reasonable advance notice (typically 5-10 business days for scheduled audits, immediate access for cause audits).

Records Retention

Specify the records retention period, which should align with the device's expected lifetime plus at least two years, or as required by applicable regulations (typically minimum 2 years beyond the device's last date of manufacture for FDA, or longer under EU MDR).

Ongoing Supplier Monitoring

Key Performance Indicators

Track the following metrics for each extrusion supplier:

Lot acceptance rate: Percentage of lots that pass incoming inspection without nonconformance.
Dimensional capability: Cpk values for critical dimensions, calculated from incoming inspection data. A Cpk of 1.33 or higher indicates a capable process.
On-time delivery: Percentage of orders delivered on or before the agreed date.
Lead time consistency: Variability in actual lead times vs. quoted lead times.
Nonconformance rate: Number and severity of nonconformances per quarter.
CAPA closure timeliness: Average time to close corrective actions.

Periodic Re-Audit

Schedule re-audits of the extrusion supplier at least annually, or more frequently if performance metrics indicate a deteriorating quality trend. The re-audit should focus on:

Changes since the last audit (new equipment, new personnel, process changes)
Status of open corrective actions from previous audits
Review of recent production records and nonconformance data
Verification of ongoing process control (SPC data review)
Environmental monitoring data (if cleanroom production)

Incoming Inspection Strategy

The rigor of incoming inspection for extruded tubing should be calibrated to the supplier's demonstrated capability:

New supplier / newly qualified process: 100% inspection of critical dimensions on every lot until sufficient data is available to demonstrate capability.
Established supplier, capable process: Reduced inspection based on statistical sampling plans (e.g., ANSI/ASQ Z1.4). The reduction must be justified by Cpk data showing the process is in statistical control and capable.
Supplier with quality concerns: Return to tightened inspection until the issue is resolved and the process is re-qualified.

Practical Recommendations

Start with DFM

Before qualifying a supplier, conduct a design for manufacturability (DFM) review with the supplier's engineering team. Present your tubing specification and ask the supplier to evaluate it against their capabilities. Medical Extrusion Technologies offers DFM reviews as a standard part of their development process. This step identifies potential issues early — tolerances that are tighter than the supplier's demonstrated capability, geometries that are difficult to tool, or materials that the supplier has not processed before.

Specify Function, Not Just Dimensions

Where possible, specify tubing by its functional requirements (burst pressure, flow rate, kink resistance, torque response) in addition to dimensional requirements. This gives the supplier flexibility to optimize the process for functional performance rather than chasing dimensions that may not perfectly correlate with device function.

Validate with Production-Representative Material

Process validation must use the same resin grade, supplier, and lot protocol that will be used in production. If the validation is run with a different lot or grade, the validation results may not be representative of production performance.

Plan for Tooling Wear

Extrusion tooling (dies and pins) wears over time, and wear affects tubing dimensions. Establish a tooling inspection and replacement schedule as part of the quality agreement. Define the criteria for tooling replacement (dimensional drift, surface finish degradation) and who bears the cost.

Build Redundancy

For critical tubing components, qualify at least two suppliers or ensure that your primary supplier has multiple extrusion lines capable of producing your tubing. A single extrusion line represents a single point of failure — if the line goes down, production stops.

Document Everything

Under the FDA's QMSR (effective February 2, 2026), which incorporates ISO 13485 by reference, the expectation for documented evidence of supplier qualification, process validation, and ongoing monitoring is higher than ever. The alignment between FDA's QMSR and ISO 13485 underscores the need for validated processes with proper documentation, including certificates of compliance, lot records, and change control.